alexa Methotrexate Treatment for Alopecia Areata with Greater than 50% Involvement

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Current and Future Trends in Surgery

New York, USA

International Conference on Food and Nutrition

Paris, France
Methotrexate Treatment for Alopecia Areata with Greater than 50% Involvement

Alopecia areata is a non-scarring alopecia that can present as patches of hair loss (areata, AA), complete scalp hair loss (totalis, AT) or complete scalp and body hair loss (universalis, AU). It is an autoimmune disease mediated via CD8+ T-cell activation and NKG28 signaling targeting the hair bulb. Previous reports indicate that systemic treatment with methotrexate (MTX) benefits patients with AT or AU when used alone or with systemic corticosteroid administration. This study evaluates the utilization of MTX as a treatment modality in patients with alopecia areata who have greater than 50% hair loss.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top